Determination of SYUIQ-F5, a Novel Telomerase Inhibitor and Anti-tumor Lead-Compound, in Tissues and Plasma Samples by LC–MS–MS: Application to a Tissue Distribution Study in Rat
Huiyu Xiong(Sun Yat-sen University), Min Huang(Sun Yat-sen University), Huichang Bi(Southern Medical University), Tian‐Miao Ou(Sun Yat-sen University), Guoping Zhong(Sun Yat-sen University), Xiaoling Qin(Sun Yat-sen University), Yuguang Wen(Guangzhou Psychiatric Hospital), Minjing Zhao(Sun Yat-sen University), Jinqing Hu(Zhejiang Sci-Tech University), Rifang Liao(Sun Yat-sen University), Zhi‐Shu Huang(Sun Yat-sen University)
Cited by 3
Related Papers
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
|Acta Pharmaceutica Sinica B|2020|129
Optimization of harvesting, extraction, and analytical protocols for UPLC-ESI-MS-based metabolomic analysis of adherent mammalian cancer cells
|Analytical and Bioanalytical Chemistry|2013|126
Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1–p53 signaling pathways
|Toxicology Letters|2015|122
Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation
|Chemico-Biological Interactions|2015|117